Related by context. All words. (Click for frequent words.) 75 Tibotec BVBA 73 Therapeutic Competitors Companies 73 Inc Therapeutic Competitors 73 Therapeutic Competitors Report 73 Initiates Clinical Trial 72 Therapeutic Competitors companiesandmarkets.com adEgemonye 72 Catalyst Biosciences 71 Initiates Enrollment 71 Boehringer Ingelheim MedImmune 71 Announce License Agreement 71 Files IND 71 Initiates Phase III 71 SANOFI AVENTIS 71 Initiates Phase II 70 Licenses Novel 70 Initiates Clinical 70 Therapeutic Competitors 70 Initiates Clinical Trials 70 Begins Dosing 70 BIOTECHNOLOGY SOURCE 70 Reports Preclinical Data 69 Crucell NV NYSE Euronext 69 Submits Biologics License Application 69 Completes Patient Enrollment 69 Receives Milestone Payment 69 Crofelemer budesonide foam 69 Announce Collaboration Agreement 69 MEDAREX 69 OTCBB PYTO 69 dihydrochloride Tablets 69 Announce Merger Agreement 69 Aestus Therapeutics 69 5 lipoxygenase activating 69 pralatrexate injection folate analogue 69 Aerie Pharmaceuticals 68 NASDAQ ALNY 68 Presents Positive 68 OTCBB IMUC 68 Quark Biotech 68 Syntonix Pharmaceuticals 68 Kiadis 68 MBRX 68 Receives Orphan Drug Designation 68 Vaccine Adjuvant 68 commercializing Loramyc ® 68 Agios Pharmaceuticals 68 Kosan dependence 68 Nasdaq PGNX 68 visit http:/www.martek.com 68 ASX ANX 68 Alligator Bioscience AB 68 Receives Fast Track 68 IG HCR ;) CO 68 Orbitz Worldwide visit corp.orbitz.com 68 Receive Milestone Payment 68 NASDAQ CRXL 68 Completes Enrollment 68 Taglich Brothers Initiates Coverage 68 Namenda Memantine HCl 68 Tezampanel 68 Successfully Completes Phase 68 Announces Poster Presentations 68 Regado Biosciences 68 COMUNICADO DE 68 Presents Preclinical 68 Nasdaq RXII 67 R MSCRAMM 67 Awarded Qualifying Therapeutic 67 AMEX RGN 67 Regulus Therapeutics 67 Hematology Molecular Pathology 67 Nasdaq CRXL 67 TRACON Pharmaceuticals 67 Pharma Merck Serono 67 Submits NDA 67 Receives Approvable Letter 67 Develop Novel 67 Cephalon GlaxoSmithKline 67 Initiates Phase 2b 67 Meets Primary Endpoint 67 acne impetigo 67 Cylene Pharmaceuticals 67 Kuvan R 67 Receives Orphan Drug 67 NYSE Amex PBTH 67 subsidiaries visit http:/www.apricusbio.com 67 Initiates Dosing 67 Exherin 67 CysDisplay R 67 KYTHERA Biopharmaceuticals Inc. 67 NYSE Amex YMI 67 Merck Serono Nycomed 67 Alnylam Nasdaq ALNY 67 Enters Into Collaboration 67 Cenomed 67 Inc. www.prometic.com 67 Melior Discovery 67 Fovea Pharmaceuticals 67 Shrink OTCBB INKN 67 Phase 2b Clinical Trial 67 Resolvyx Pharmaceuticals 67 Idera Pharmaceuticals 67 VentiRx Pharmaceuticals 67 SIX RO ROG 67 Quark Pharmaceuticals 67 Receives CE Marking 67 NASDAQ OMX NORDIC ACTI 67 OTCBB IBPM 67 Commercialize Novel 67 XL# anticancer compounds 67 Active Biotech AB 67 Handok Pharmaceuticals 67 Transcept Pharmaceuticals 67 Galderma SA 67 Rheumatoid Arthritis Drug 67 NASDAQ PPDI 67 Inc. dba Vitro 67 Antisense Pharma GmbH 66 HuCAL PLATINUM R 66 Immunotherapeutic 66 IPSEN 66 TRANSDUR ™ 66 MultiCell Technologies 66 Nereus Pharmaceuticals 66 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 66 Astex Therapeutics Limited 66 GVAX ® 66 Ltd Therapeutic Competitors 66 ASE SVA 66 PHARMACEUTICALS INC 66 OTC BB PVCT 66 Mersana Therapeutics Inc. 66 GTC NASDAQ GTCB 66 FOLOTYN ® 66 Nasdaq XTLB 66 Cara Therapeutics 66 PharmaVitae Profile 66 AUDIO PROVIDED BY 66 Announces Licensing Agreement 66 M.D. Ph.D. 66 Idec Roche Takeda 66 Nasdaq DVAX 66 Marillion Pharmaceuticals 66 Patient Enrollment 66 t2cure GmbH 66 Nasdaq TARG 66 visit www.genenews.com 66 OTCBB AGNM 66 Merck OSI Pharmaceuticals 66 OTCBB FCSC 66 Graffinity Pharmaceuticals 66 OTCBB HNAB 66 Epiphany Biosciences 66 Quark Biotech Inc. 66 JV SpeBio 66 immunotherapies 2A/Furin 66 Luveris R Ovidrel R 66 Presents Preclinical Data 66 Alnylam Pharma 66 GVAX cancer 66 LibiGel ® 66 Prism Pharmaceuticals 66 Alvine Pharmaceuticals 66 Announces License Agreement 66 Ascenta Therapeutics 66 PROLOR Biotech Inc. 66 KAI Pharmaceuticals 66 Oxford Genome Sciences 66 Conatus Pharmaceuticals 66 BioSante Pharmaceuticals Announces 66 novel orally inhaled 66 Inc. Nasdaq OXGN 66 allosteric modulator PAM 66 NASDAQ FLML 66 Avila Therapeutics 66 Cerenis Therapeutics 66 non nucleoside inhibitor 66 AVAX Technologies Inc. 65 TO AVOID PREGNANCY WHILE 65 Granted Orphan Drug 65 IMRX 65 Announce Licensing Agreement 65 Cardioxyl Pharmaceuticals 65 Jumps Higher 65 Omeros Corporation 65 FDA APPROVES 65 Taiho Pharmaceutical 65 Potelligent Technology 65 Bristol Myers Squibb sanofi 65 First Patient Enrolled 65 Creabilis Therapeutics 65 includes Dideco CarboMedics 65 AVANT Immunotherapeutics 65 OSI commercializes Macugen 65 Isis Pharma 65 Crucell NV Euronext 65 Nasdaq ONXX 65 Announce Initiation 65 Frankfurt XMP 65 Combination REOLYSIN R 65 Arno Therapeutics 65 Drug Candidate 65 Announces Tentative Approval 65 Undisclosed Investors 65 Presents Positive Preclinical 65 DOV Pharmaceutical Inc. 65 Metabolic Disease 65 PRN FDA Approves 65 OTCBB OHRP 65 -Pahuta 65 Inc. ProMetic www.prometic.com 65 www.ucb group.com 65 Shai Novik President 65 Essentialis 65 Brussels THR 65 Personalized Immunotherapy 65 miRagen Therapeutics 65 Provides Shareholder 65 StromaCel Inc. 65 Nasdaq ALNY 65 Saladax Biomedical 65 Urigen Pharmaceuticals Inc. 65 Mylan Receives Approval 65 Fresenius Biotech 65 Corp. www.anavex.com 65 Oral Suspension USP 65 Ltd. OTCBB IMUC 65 Inc. Nasdaq IMGN 65 Sign License Agreement 65 Durect Corporation 65 Announcement acc 65 Novartis Organon 65 Aeolus Pharmaceuticals Announces 65 AllPennyStocks.com Spotlights 65 FDA Clears 65 Gendux AB 65 Pernix Therapeutics 65 Novartis VIRT X 65 Immunotope 65 JAK2 Inhibitor 65 UGNE 65 WeissComm Partners +#-#-#-# 65 Submits Response 65 Vaccinex 65 Nasdaq VNDA 65 NASDAQ BDSI 65 Veronate R 65 visit http:/www.mannkindcorp.com 65 Novel Antibody 65 GlaxoSmithKline MedImmune 65 Abstract Accepted 65 Nasdaq EPCT 65 Visit www.BASInc.com 65 Inc. OTCBB APNS 65 Initiate Phase 65 Submits IND 65 molecular chaperone regulation 65 Amira Pharmaceuticals 65 NYSE Amex AEN 65 Inovio Pharmaceuticals 65 Nitec Pharma 65 Nasdaq ANPI 65 Cavit Sciences Inc. 64 researches develops licenses 64 commercialize Aganocides 64 Extends Collaboration 64 Anadis Limited 64 please visit http:/www.vandapharma.com 64 ImmunoCellular Therapeutics 64 MONSTERSTOX.COM Monsterstox.com 64 TM Aganocide 64 Develops Novel 64 Teikoku Pharma USA 64 OMRIX Biopharmaceuticals Inc. 64 platform HDL Mimetic 64 molecular imaging radiopharmaceutical 64 Advancis Pharmaceutical Corporation 64 INTERNATIONAL HOLDINGS INC. 64 Roche OTC RHHBY 64 NASDAQ RNAI 64 Inc. www.micromet inc.com 64 OTCBB HXBM developer 64 InNexus Biotechnology 64 developing chemokine 64 commercialize Aganocide compounds 64 Present Preclinical Data 64 GendeLLindheim BioCom Partners 64 TSX CTI 64 Cenix BioScience 64 Nasdaq ENMD 64 Files Shelf Registration Statement 64 THERAPEUTICS 64 visit http:/www.PAREXEL.com 64 acetonide FA 64 Initiate Clinical Trial 64 Mesoblast Limited ASX MSB 64 neurology immunology 64 Adenosine Therapeutics 64 Aloxi ® 64 Patient Enrolment 64 FoldRx Pharmaceuticals Inc. 64 Cyclacel Pharmaceuticals 64 FORMA Therapeutics 64 KAI Pharmaceuticals Inc. 64 OTCBB TDLP 64 ERYtech 64 Nasdaq CLDX 64 BioInvent International 64 Xcytrin R 64 Staphylococcus aureus Immune Globulin 64 Akesis Pharmaceuticals 64 FDA Accepts 64 Genaera Corporation 64 Lexicon Genetics Incorporated 64 www.ucb.com 64 Raven Biotechnologies 64 Issued Patent 64 ISTO Technologies 64 Takeda Kyowa Hakko Kirin 64 PAION AG ISIN 64 Acrongenomics Inc. 64 ZFP Therapeutics 64 MOVIPREP R 64 cosmetic cosmeceutical products 64 Enzon Pharmaceuticals Inc 64 BIOPHARMA 64 OTCBB CHKT 64 Sankyo Pharma 64 Pharmos Corporation 64 Announce Early Termination 64 kidney urologic 64 Altair Therapeutics 64 Supernus Pharmaceuticals 64 technology visit http:/www.genmab.com 64 Zygogen 64 Emisphere Technologies 64 ABI OTCBB AMAR 64 EnVivo Pharmaceuticals 64 Retains CCG Investor Relations 64 Aphton Corporation 64 Launches Generic Version 64 Nasdaq AVNC 64 including thyroiditis RA 64 BioProgress plc 64 Genentech GlaxoSmithKline 64 Flamel Technologies 64 Nasdaq ENZN 64 Euronext Paris Code Isin 64 Gentamicin Surgical Implant 64 LSE SHP.L 64 Commences Phase 64 Novel Oral 64 ZARS Pharma 64 OTCBB QTXB 64 Cypress Bioscience Inc 64 Connetics Corporation 64 COLLABORATION WITH 64 Cerus Corporation 64 VIA Pharmaceuticals 64 AVXL 64 Enrolls First 64 OTCBB CHKT biotechnology 64 oncolytic virus therapies 64 * olmesartan medoxomil 64 Biotherapeutic 64 OTCBB AMAR 64 Nasdaq IDIX 64 Investigational Compound 64 Restructures Operations 64 http:/www.unigene.com 64 SciClone Pharmaceuticals 64 Supernus Pharmaceuticals Inc. 64 BioSante Pharmaceuticals NASDAQ BPAX 64 Tomorrow Cures 64 Taisho Pharmaceuticals 64 HuCAL GOLD R 64 Nasdaq ACAD 64 Reveals Positive 64 Cellgate Inc. 64 Inc. Nasdaq MITI 64 www.rxipharma.com 64 By JAMAAL ABDUL 64 Lentigen Corporation 64 Nasdaq IDRA today 64 Astex Therapeutics 64 Signs Merger Agreement 64 J Allergy Clin 64 TRANSDUR ® 64 ANIK 64 OTCQB CTIX 64 OTCBB IGXT 64 DNA methyltransferase inhibitors 64 Primus Pharmaceuticals 64 Phenomix Corporation 64 Agonist MABA program 64 DRRX 64 Nihon Kohden Corporation 64 MEK Inhibitor 64 Announces Initiation 64 ZyStor Therapeutics Inc. 64 Submits Application 64 RECOTHROM ® 64 Collaborators Present 64 Nasdaq IMGN 64 migraine headaches neuropathic pain 64 Nasdaq SPPI 64 NASDAQ DCGN 64 candidate MyVax 64 Corixa Corporation 64 Alcortin R 64 NASDAQ IDRA 63 Syntonix 63 Finalizes Joint Venture 63 OTCBB URGP specialty 63 Nasdaq HALO 63 RNAi Therapeutics 63 Report companiesandmarkets.com adds 63 BayStreet.ca Research Alert 63 Completes Dosing 63 PharmaNova 63 Cadila Pharmaceuticals named 63 BioFocus DPI Galapagos 63 TapImmune Inc. 63 Nasdaq CYCC 63 Aradigm Logo 63 Immunomedics Announces 63 estrogen receptor beta agonist 63 Napo Pharmaceuticals 63 visit www.targanta.com 63 Inc. OTCBB CYKN 63 Amends Agreement 63 Obtains Exclusive License 63 LLSR 63 Nasdaq MRNA 63 OLGX 63 Prochymal TM 63 Completes Patient Enrolment 63 Xytis 63 DayTradersDigest.com Profiles 63 Myrexis Inc. 63 Apricus Biosciences 63 Addrenex Pharmaceuticals 63 markets HP Acthar 63 NASDAQ ISIS 63 Quark Pharmaceuticals Inc. 63 OTCBB NPHC 63 Collaborators Publish 63 NASDAQ INFI 63 Organon Pharmaceuticals 63 Locteron exclusively 63 small molecule thrombopoietin 63 Demonstrates Sustained 63 Biodesix 63 OTCBB IMNR 63 Signs License Agreement 63 AMEX ILI 63 Systemic Delivery 63 Selecta Biosciences 63 developing ostarine selective 63 Demonstrates Positive 63 TELINTRA R 63 Regeneron Pharma 63 NASDAQ OMX Nordic ACTI 63 DEERFIELD Ill. Business Wire 63 NASDAQ CORT 63 Pharmion Corporation 63 Newron Pharmaceuticals SpA 63 Drug Fails 63 Obstructive Pulmonary Disease 63 equine osteoarthritis marketed 63 TSX NVN 63 Nasdaq OMER biopharmaceutical 63 NOVAVAX 63 include Healive TM 63 NYSE Amex RNN 63 OTCQX QRXPY 63 Nasdaq ZGEN 63 Psoriasis Drug 63 Selective Electrochemical Tumor Ablation 63 apply Enhanze technology 63 THERAPEUTICS INC 63 BIOGEN IDEC 63 GNSZ 63 Gemin X Biotechnologies 63 Anti Infective 63 Therion Biologics 63 Receives Tentative Approval 63 NV Organon 63 Locked Nucleic Acid 63 Hsp# Inhibitor 63 AB OMXS BINV 63 Gets FDA Clearance 63 Ception Therapeutics 63 NASDAQ DIGE 63 GENZYME 63 PsychoGenics 63 Barrier Therapeutics Inc. 63 HuCAL PLATINUM ® CysDisplay 63 Prometheus Laboratories 63 MEDICAL PHARMACEUTICAL 63 GeneThera Inc. 63 Nasdaq NPSP 63 Nasdaq PHRM 63 SPL# Gel vaginal microbicide 63 bioMerieux SA 63 Anticancer Agent 63 Zelos Therapeutics 63 Announce Definitive Agreement 63 Terminate Merger Agreement 63 sanofi aventis Bayer Schering 63 EMD Biosciences Inc. 63 TSX VIR 63 Ipsen Euronext FR# 63 CEPHALON 63 Psivida 63 NASDAQ AVEO biopharmaceutical 63 NASDAQ KERX 63 TRBN 63 LEAD Therapeutics 63 R Saizen R 63 Phase IIb Trial 63 Teikoku Seiyaku 63 Archemix Corp. 63 NASDAQ EMIS 63 Expand Collaboration 63 Nanobiotix 63 Inc. Nasdaq CRTX 63 Bradmer Pharmaceuticals 63 Protein Polymer Technologies 63 Recombinant Human 63 Sign Licensing Agreement 63 Alnara Pharmaceuticals 63 Earns Milestone Payment 63 Nasdaq PCOP 63 molecular therapeutics immunotherapies 63 NASDAQ IMMU 63 PRNewswire FirstCall Pharmacopeia 63 please visit www.dyax.com 63 Clinical Trial Results 63 OTC BB PVCT http:/www.pvct.com 63 LIFE SCIENCES 63 Daytradersdigest.com 63 About Sangamo Sangamo 63 PRAECIS PHARMACEUTICALS INCORPORATED 63 rxRNA 63 DARA logo 63 LOUISMO 63 HuCAL R 63 sirtuin inhibitor program 63 please visit www.medicinova.com 63 GSK Rare Diseases 63 Cellegy Pharmaceuticals 63 Terminates Agreement 63 Disease IBD 63 Auxilium Pharma 63 Nicotine Vaccine 63 ARRY # 63 Vascular Disrupting Agent 63 ESBATech AG 63 Sanofi aventis EURONEXT SAN 63 ophthalmics 63 Announce Licensing 63 purinergic receptors P#X# 63 Inc. Nasdaq ATHX 63 Sinks Lower 63 Romidepsin 63 COLAZAL R 63 SNPY 63 Revotar Biopharmaceuticals AG 63 Expands Scientific Advisory 63 Tibotec Virco 63 asthma COPD Chronic 63 NOVN 63 Enters Into Licensing Agreement 63 Files Investigational 63 Chugai Pharma USA 63 Alnylam Pharmaceuticals Nasdaq ALNY 63 AAG geldanamycin analog 63 Chronogen 63 IDEV Technologies 63 CCR9 antagonist 63 ZFNs clinical trials 63 NOVARTIS 63 Phase 2b Trial 63 NASDAQ OGXI 63 Fujisawa Healthcare Inc. 63 AGY Therapeutics 63 developing Surfactant Replacement 63 Tacere 63 Freedom Meditech 63 Lexicon Genetics 63 Ingenium Pharmaceuticals AG 63 ImaRx Therapeutics 63 Nasdaq MSON designs 63 Chroma Therapeutics 63 Vaccine Adjuvants 63 CardioVascular BioTherapeutics 63 NASDAQ BJGP 63 Debiopharm SA 63 NASDAQ ENMD 63 Colaris Colaris AP 62 Biomarker Study 62 TOPICA 62 Tobira Therapeutics 62 Merck Sante sas 62 Oral Calcitonin 62 Paris IPN Euronext 62 programs visit http:/www.bionovo.com 62 EMD Merck 62 SWISS BSLN 62 Kinase Inhibitor 62 TRADING LOWER ON #.#X 62 personalized cellular immunotherapy 62 MorphoSys AG FSE MOR 62 Lupus Drug 62 Tetraphase Pharmaceuticals 62 SansRosa 62 Announces FDA Clearance 62 Inc. www.sanuwave.com 62 Successfully Completes Tender Offer 62 BCLI 62 #M MarketCap [002] 62 PDL BioPharma Inc 62 Bristol Myers Squibb Celgene 62 Merck Serono division 62 symbol AVXL 62 OTCBB CGXP 62 Transdel Pharmaceuticals Inc. 62 ROSG 62 Sunshine Biopharma 62 Prostate Cancer Vaccine 62 Tranzyme Pharma 62 Procyon Biopharma 62 Bayhill Therapeutics 62 YM AIM YMBA 62 Preclinical Study 62 ACADIA Pharmaceuticals 62 hyaluronidase enzyme 62 Genentech sanofi aventis 62 developing Zerenex ferric 62 Novel Therapeutics 62 Robert L. Bratzler 62 Osmetech plc 62 Budesonide foam crofelemer 62 Argenta Discovery 62 small molecule vanilloid 62 Oxxon Therapeutics 62 Welcomes Analyst Initiation 62 ERYtech Pharma 62 Phase 2a Trial 62 Nicotine Conjugate Vaccine 62 Metabasis Therapeutics 62 OTCBB VCRT 62 Attracting Bullish Investors 62 Kelly Luethje #-#-# 62 Alseres Pharmaceuticals 62 Canexus targets 62 Neurimmune 62 UltiMAb 62 Xenon Pharmaceuticals 62 Oral Fingolimod 62 SinuNase ™ 62 Neutrolin ® 62 topical antifungal product 62 BIOTECHNOLOGY 62 Synthetic Peptide 62 Pruvel TM 62 Nanobody R 62 Heartscape Technologies 62 include PLX IBD 62 Adamis Laboratories 62 commercializing oxidized glutathione 62 AMEX REX 62 telomerase therapeutic 62 Cytokine PharmaSciences 62 Inc. NASDAQ MBLX 62 Vical Incorporated 62 Nasdaq SGMO 62 Q2 Adj 62 Captisol enabled 62 PRNewswire FirstCall YM BioSciences 62 Virion Systems 62 Coronado Biosciences 62 BAYRY 62 Vitamin D analogue 62 BUPHENYL R 62 Wafer polifeprosan 62 Cephalon GlaxoSmithKline Schering Plough 62 Inotek Pharmaceuticals Corporation 62 SyntheMed Inc. 62 Paris EURONEXT SAN 62 OTC BB EMIS 62 Cascade LifeSciences 62 Nasdaq VRTX today 62 therapeutic monoclonal antibody 62 ONYX PHARMACEUTICALS 62 include ClindaReach TM 62 CyDex Pharmaceuticals Inc. 62 RECORDATI 62 Synageva BioPharma Corp. 62 Momenta Pharmaceuticals MNTA 62 Auriga Laboratories Inc. 62 Aganocide ® 62 BioLife Solutions 62 MAP Pharmaceuticals generates 62 dedicated CHAT ROOM 62 visit corp.orbitz.com 62 Ercole Biotech 62 XOMA XOMA 62 Phase IIb Clinical Trial 62 HELSINN 62 cathepsin K inhibitor 62 Dendritic Nanotechnologies Inc. 62 label Lipofen R 62 Restructures Debt 62 NASDAQ CLSN 62 essential thrombocythemia ET 62 Copegus ® 62 Cardium Therapeutics TM 62 Beerse Belgium 62 R lenalidomide 62 Qiagen NASDAQ QGEN 62 ProChon Biotech 62 HCV Protease Inhibitor 62 pharmacogenomic translational research 62 NicVAX TM 62 Presidio Pharmaceuticals 62 INDICATED LOWER 62 www.antigenexpress.com 62 ALTROPANE R 62 Nasdaq FURX 62 Companies Mentioned * 62 MEDICAL DEVICES 62 Enanta Pharmaceuticals 62 Neose Technologies 62 Glaxo Wellcome plc 62 OTCBB PYTO FWB ET6 62 OTCBB CVBT 62 HXBM 62 visit www.virtualscopics.com 62 urology oncology 62 THR beta agonist 62 Cephalon Oncology 62 Partnering Agreements 62 RGIN 62 selective immunoproteasome inhibitor 62 TKPHF 62 developing ACAPODENE 62 OTCBB NRGX 62 Eckard Weber 62 KaloBios Pharmaceuticals Inc. 62 vapreotide acetate 62 Inc. OTCBB MBCI 62 Completes Recapitalization 62 commercialize becocalcidiol patented 62 ASML Novellus Systems 62 AviaraDx 62 Repligen Corporation 62 Achieves Primary Endpoint 62 Explores Strategic Alternatives 62 STO SOBI 62 OMRIX Biopharmaceuticals 62 Milestone Payment 62 website www.celsion.com 62 Sirion Therapeutics 62 Partnering Guide 62 LEVADEX TM 62 Endures Analyst Downgrade 62 Germany FSE SCH 62 GENR 62 Receives SFDA Approval 62 CeNeRx BioPharma 62 COMPLETES ACQUISITION OF 62 Adamis Pharmaceuticals 62 Liprotamase 62 BTG plc 62 ANNOUNCES ACQUISITION OF 62 delivers fluocinolone acetonide FA 62 BOB SANDERS NEW HAMPSHIRE 62 Anti Tumor 62 Genentech Wyeth Pharmaceuticals 62 FOLFOX6 chemotherapy regimen 62 Milestone Payments 62 Glaxosmithkline Plc 62 Nycomed GmbH 62 Nasdaq SOMX 62 CNS Disorders 62 Amex KAL 62 Koronis Pharmaceuticals 62 NasdaqSC ASTM 62 Nasdaq REGN 62 CRXL 62 Pepscan Therapeutics 62 Iconix Pharmaceuticals 62 PAUL Minn.MN 62 RNA antagonists 62 Erica Elchin #-#-# 62 Frozen Shoulder syndrome 62 NovaBay Pharmaceuticals 62 Inc. http:/www.endocare.com 62 Oxford BioTherapeutics 62 P#X# antagonist 62 Receives Complete Response 62 Inc. AMEX YMI 62 RegeneRx Biopharmaceuticals Inc. 62 NASDAQ BMRN 62 IMiDs ® 62 Gastrotech 62 Completes Merger With 62 tiapamil 62 Ohr Pharmaceutical Inc. 62 Mirna Therapeutics 62 Inc. NASDAQ SIRT 62 visit www.PAREXEL.com 62 Idec Roche 62 NASDAQ SOMX specialty 62 ChemGenex Pharmaceuticals Limited 62 PRNewswire FirstCall Rosetta Genomics 62 Breakthroughstocks.net EXPLOSIVE news 62 Alethia Biotherapeutics 62 Nasdaq PARD 62 LWLG 62 Euronext SAN 62 SWOT Analysis Aarkstore Enterprise 62 ARYX 62 Pharmacopeia PCOP 62 Hainan Helpson Medical 62 Juventas Therapeutics 62 Trellis Bioscience 62 Progenics Pharmaceuticals 62 Inc. www.chemaphor.com uses 62 Newron Pharmaceuticals 62 immatics 62 Profectus Biosciences 62 IMPACS R 62 Expression Pathology 62 Arthritis Drug 62 REGENERX BIOPHARMACEUTICALS INC. 62 AstraZeneca MedImmune 62 Nasdaq IMMU 62 Other ImmunoGen collaborative 62 NASDAQ ABII 62 Micromet BiTE 62 Saegis Pharmaceuticals 62 please visit www.metabolon.com 62 Mutually Agree 62 Nasdaq HALO biopharmaceutical 62 Completes Financing 62 Nasdaq IDRA 62 DermTech International 62 Develop Innovative 62 Novel Vaccine 62 OPKO Health 62 Migraine Drug 62 Copegus R 62 Femring ® 62 Nasdaq DYAX 62 Novartis Wyeth 62 Nasdaq NRGN 62 Phytomedics Inc. 62 Arriva Pharmaceuticals 62 Neuronyx Inc. 62 Vicor Technologies 62 Epeius Biotechnologies Corporation 62 Nasdaq INCY announced 62 mitogen activated ERK kinase 62 Vitrasert R 62 Inc. OTCBB ALRX 62 Targanta Therapeutics Corporation 62 renin inhibition promising 62 Merrimack Pharmaceuticals 62 Maven Semantic 62 Novel Therapeutic 62 NASDAQ ARRY 62 Ceflatonin R 62 Amex PTN 62 palonosetron hydrochloride Injection Dacogen 62 Nasdaq ZIOP 62 anti botulism antibody 62 MSCRAMM ® 62 Ascent Therapeutics 62 Inc. Nasdaq VIAP 62 Archexin 62 Crit Rev 62 Bionomics Limited 62 selective androgen receptor modulators 61 syndrome overactive bladder 61 Nasdaq BJGP 61 Inc. NASDAQ SNUS 61 Xenoport Inc. 61 Ventaira Pharmaceuticals 61 Joins OTCQX 61 Nasdaq KOSP 61 ISTO Technologies Inc. 61 candidate deforolimus 61 Bacterin develops manufactures 61 Predictive medicine 61 FivePrime Therapeutics 61 Inc. OTCBB SPRX 61 Mersana Therapeutics 61 Founding Scientist 61 Antibody Drug Conjugate 61 LibiGel transdermal testosterone gel 61 OTCBB EMIS 61 RealPennies.com RealPennies.com 61 NASDAQ ADLR 61 Insmed Incorporated 61 Amarillo Biosciences Inc. 61 LEVADEX ™ 61 Announces Effective Date 61 Cytta Corp. 61 Tamar Howson 61 Ovitrelle R Serostim 61 NYSE Amex RGN 61 pentadentate logo R 61 Curr Opin 61 gets USFDA nod 61 Shareholders Approve Acquisition 61 Phase 2a Clinical Trial 61 Acceleron Pharma Inc. 61 highly selective inhibitor 61 Santhera Pharmaceuticals 61 enhanced skin permeation 61 ThromboGenics NV 61 Nasdaq OSIR 61 Therapeutic Vaccines 61 Adventrx Pharmaceuticals 61 Rhein Biotech GmbH 61 JEFF FEINGOLD NEW HAMPSHIRE 61 PVCT 61 Oasmia 61 Selecta Biosciences Inc. 61 Per Olof Wallström 61 Thrombin topical Recombinant 61 OTCBB PWRM.OB 61 BioSpecifics Technologies Corp. 61 Friedreich Ataxia FRDA 61 Nasdaq APPY 61 Nuvelo Announces 61 dutogliptin 61 CINDY KIBBE NEW HAMPSHIRE 61 Diatos SA 61 About Positron Positron 61 FY# Loss Narrows 61 Ichor Medical Systems 61 Endocrinol 61 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 61 ACE BioSciences 61 please visit www.eisai.com 61 Coria Laboratories 61 ASX BLT 61 BNVID 61 Biovitrum AB 61 Secures Financing 61 Stromedix 61 Nasdaq IDIX biopharmaceutical 61 Fibrocell Science Inc. 61 Arch Biopartners 61 HealthSonix Inc. 61 Tri Isthmus Group 61 candidates Azedra TM 61 please visit http:/www.atherogenics.com 61 SPL OTCQX SPHRY 61 Asthma COPD 61 Nasdaq KERX 61 Cutanea Life Sciences 61 humanized therapeutic 61 AMEX ISV 61 Penwest Pharma 61 China Aoxing Pharmaceutical 61 Pulmo BioTech Inc. 61 ViroChem Pharma Inc. 61 Preclinical Data 61 Q1 Adj 61 NASDAQ MNKD focuses 61 Inc. Nasdaq ALNY 61 glucokinase activator 61 www.sanuwave.com 61 CRMD pharmaceutical 61 Revises FY# Outlook 61 Kissei Pharmaceuticals 61 Alantos Pharmaceuticals 61 ICOS Corporation 61 developing Zerenex TM 61 QuatRx 61 MANAGEMENT CHANGES SOURCE 61 TTHI 61 Inc. OTCBB SNWV 61 Nasdaq MBRX 61 novel MetAP 2 61 Eligard R 61 Aganocide 61 Biomarker Discovery Center 61 Nasdaq IPXL 61 TNGN 61 Successfully Completes Acquisition 61 Alnylam Pharmaceuticals Inc 61 QIAGEN GmbH 61 neuropathic pain metabolic diseases